OPK logo

OPK
Opko Health Inc

27,614
Mkt Cap
$974.07M
Volume
5,970.00
52W High
$1.60
52W Low
$0.9769
PE Ratio
-4.71
OPK Fundamentals
Price
$1.29
Prev Close
$1.27
Open
$1.27
50D MA
$1.17
Beta
0.96
Avg. Volume
2.3M
EPS (Annual)
-$0.3004
P/B
0.81
Rev/Employee
$266,760.00
$974.14
Loading...
Loading...
News
all
press releases
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
OPKO Health leans on RAYALDEE and key partnerships, such as BioReference and 4Kscore, as it ramps toward mid-2026 diagnostics breakeven.
News Placeholder
More News
News Placeholder
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) has earned an average recommendation of 'Hold' from the six brokerages that are covering the company, Marketbeat reports. One investment analyst has...
News Placeholder
HC Wainwright Boosts Earnings Estimates for OPKO Health
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of OPKO Health in a research note issued to investors on Wednesday, April...
News Placeholder
Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of OPKO Health in a research report issued to clients and investors on Wednesday, April 29th. HC Wainwright analyst Y. Chen expects that the biotechnology compa...
News Placeholder
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.
News Placeholder
OPKO Health (NASDAQ:OPK) Hits New 1-Year Low - Should You Sell?
OPKO Health (NASDAQ:OPK) Reaches New 1-Year Low - What's Next...
News Placeholder
OPKO Health Q1 2026 Earnings Call: Complete Transcript
read more...
News Placeholder
OPKO Health Q1 Earnings Call Highlights
OPKO Health (NASDAQ:OPK) reported first-quarter 2026 results and highlighted continued progress across its ModeX Therapeutics pipeline, along with ongoing restructuring in diagnostics and growth in international pharmaceutical operations. ModeX pipeline expands clinical activity and partnerships Ch...
News Placeholder
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of -2.94% and -4.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available